| Vol. 10.23 – 16 June, 2021 |
| |
|
|
| Researchers showed that cytoplasmic complexes composed of steroid receptor co-activators, PELP1 and SRC-3, modulated breast CSC expansion through upregulation of the HIF-activated metabolic target genes PFKFB3 and PFKFB4. [Oncogene] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The role of mini-chromosome maintenance 8 (MCM8) in glioblastomas has remained unclear. Scientists investigated the biological functions and mechanisms of MCM8 in glioma stem cells. [Oncogene] |
|
|
|
| Aberrant expression of paired-related homeobox1 (Prrx1) has been functionally associated with cancer stem cells including glioma stem cells. Prrx1 was found to be markedly upregulated in glioma specimens and elevated Prrx1 expression was inversely correlated with the prognosis of glioma patients. [Cell Death & Disease] |
|
|
|
| Circulating tumor cells enumeration at the initiation of endocrine therapy (ET), and at early and following time points was prognostic in ER-positive metastatic breast cancer starting second-line or later ET. [npj Breast Cancer] |
|
|
|
| The authors presented a detailed transcriptome and proteome atlas of the exosomes released by human lung adenocarcinoma stem-like cells. [npj Genomic Medicine] |
|
|
|
| A library of 17 C1-single and C1/C20-double modified salinomycin analogs was screened to identify compounds with improved activity against breast CSCs. [Biomedicine & Pharmacotherapy] |
|
|
|
| Using glioblastoma patient-derived stem cells, researchers identified and characterized a subset of Gal-3high glioblastoma tumors mainly within the mesenchymal subtype that are addicted to Gal-3-mediated macropinocytosis. [Communications Biology] |
|
|
|
| Through investigating cellular functions including cell proliferation and stem cell features, it was demonstrated that hypoxic cancer-associated fibroblasts exosomes transferred circHIF1A into breast cancer cells, which played an important role in CSC properties sponging miR-580-5p by regulating CD44 expression. [Cell Death Discovery] |
|
|
|
| The authors determined differences in ultrastructural morphology, proliferative capacity, and mouse-xenotransplantation characteristics of the MDA-MB-231 and MDA-MB-436 triple-negative breast tumor cell lines with the CD44high/CD24low phenotype in order to study their exosomes. [Heliyon] |
|
|
|
|
| Investigators discuss the role of LSD1 in several aspects of cancer, such as hypoxia, epithelial-to-mesenchymal transition, stemness versus differentiation of CSCs, as well as anti-tumor immunity. [Journal of Biomedical Science] |
|
|
|
| As fusion genes are expressed explicitly in cancer cells, eradicating CSC by targeting fusion genes provides yet another advantage of negligible patient side effects since normal cells remain unaffected by the drug. Scientists delineate the latest evidence on how fusion genes regulate CSC and drug resistance. [Molecular and Cellular Biochemistry] |
|
|
|
|
| AbbVie, Inc. announced new data from the Phase III GLOW study comparing the efficacy and safety of the combination of IMBRUVICA® plus VENCLEXTA®/VENCLYXTO® versus chlorambucil plus obinutuzumab for first-line treatment in patients with CLL or small lymphocytic lymphoma who had active disease requiring treatment per the International Workshop on CLL criteria. [AbbVie, Inc.] |
|
|
|
|
| June 21 -23, 2021 Virtual |
|
|
|
|
|
| Stanford University – Stanford, California, United States |
|
|
|
| Sana Biotechnology – Seattle, Washington, United States |
|
|
|
| City of Hope – Monrovia, California, United States |
|
|
|
| Northwestern University – Chicago, Illinois, United States |
|
|
|
| UT Southwestern Medical Center – Dallas, Texas, United Statess |
|
|
|
|